ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Clinical trial NCT06397703 · RECRUITING
Trial details
- NCT number
- NCT06397703
- Sponsor
- NYU Langone Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2030-04-16
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.